MOSCOW (Reuters) – Russia is expected to register a second potential vaccine against COVID-19 on Oct. 15, the vaccine’s developer said on Friday.
The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last month.
(Reporting by Maria Kiselyova; writing by Alexander Marrow; editing by Jason Neely)
